Literature DB >> 23671082

Integrating the HIV-1 assembly/maturation pathway.

Marc Potempa1, Ronald Swanstrom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23671082      PMCID： PMC3666710          DOI： 10.1073/pnas.1306620110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  21 in total

1.  Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization.

Authors:  Frauke Christ; Stephen Shaw; Jonas Demeulemeester; Belete A Desimmie; Arnaud Marchand; Scott Butler; Wim Smets; Patrick Chaltin; Mike Westby; Zeger Debyser; Chris Pickford
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors.

Authors:  Jacques J Kessl; Nivedita Jena; Yasuhiro Koh; Humeyra Taskent-Sezgin; Alison Slaughter; Lei Feng; Suresh de Silva; Li Wu; Stuart F J Le Grice; Alan Engelman; James R Fuchs; Mamuka Kvaratskhelia
Journal:  J Biol Chem       Date:  2012-03-21       Impact factor: 5.157

Review 3.  HIV-1 assembly, budding, and maturation.

Authors:  Wesley I Sundquist; Hans-Georg Kräusslich
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 4.  HIV DNA integration.

Authors:  Robert Craigie; Frederic D Bushman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

5.  New class of HIV-1 integrase (IN) inhibitors with a dual mode of action.

Authors:  Manuel Tsiang; Gregg S Jones; Anita Niedziela-Majka; Elaine Kan; Eric B Lansdon; Wayne Huang; Magdeleine Hung; Dharmaraj Samuel; Nikolai Novikov; Yili Xu; Michael Mitchell; Hongyan Guo; Kerim Babaoglu; Xiaohong Liu; Romas Geleziunas; Roman Sakowicz
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

6.  Structure-based modeling of the functional HIV-1 intasome and its inhibition.

Authors:  Lavanya Krishnan; Xiang Li; Hema L Naraharisetty; Stephen Hare; Peter Cherepanov; Alan Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

7.  Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein.

Authors:  Christopher T Lemke; Steve Titolo; Uta von Schwedler; Nathalie Goudreau; Jean-François Mercier; Elizabeth Wardrop; Anne-Marie Faucher; René Coulombe; Soma S R Banik; Lee Fader; Alexandre Gagnon; Stephen H Kawai; Jean Rancourt; Martin Tremblay; Christiane Yoakim; Bruno Simoneau; Jacques Archambault; Wesley I Sundquist; Stephen W Mason
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

8.  Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation.

Authors:  Kellie A Jurado; Hao Wang; Alison Slaughter; Lei Feng; Jacques J Kessl; Yasuhiro Koh; Weifeng Wang; Allison Ballandras-Colas; Pratiq A Patel; James R Fuchs; Mamuka Kvaratskhelia; Alan Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

9.  LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells.

Authors:  Goedele Maertens; Peter Cherepanov; Wim Pluymers; Katrien Busschots; Erik De Clercq; Zeger Debyser; Yves Engelborghs
Journal:  J Biol Chem       Date:  2003-06-09       Impact factor: 5.157

10.  HIV capsid is a tractable target for small molecule therapeutic intervention.

Authors:  Wade S Blair; Chris Pickford; Stephen L Irving; David G Brown; Marie Anderson; Richard Bazin; Joan Cao; Giuseppe Ciaramella; Jason Isaacson; Lynn Jackson; Rachael Hunt; Anne Kjerrstrom; James A Nieman; Amy K Patick; Manos Perros; Andrew D Scott; Kevin Whitby; Hua Wu; Scott L Butler
Journal:  PLoS Pathog       Date:  2010-12-09       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.